Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Clarity Pharmaceuticals Ltd (CU6 AU)
Watchlist
56
Analysis
Health Care
•
Australia
Clarity Pharmaceuticals Limited operates as a radio-pharmaceutical company. The Company focuses on the developing targeted therapies for the treatment of cancer and other serious diseases. Clarity Pharmaceuticals serves customers worldwide.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
DroneShield Ltd
•
25 Aug 2025 06:04
S&P/ASX Index Rebalance Preview (Sep 25): Potential Changes if Methodology Is Updated
The review period for the September rebalance is done and the proposals in the market consultation will be implemented. That means a lot of change...
Brian Freitas
Follow
1.8k Views
Share
bullish
•
Quantitative Analysis
•
08 Aug 2025 07:05
ASX Short Interest Weekly (Aug 1st): Ramelius Resources, Bluescope Steel, Boss Energy, Coles
We analyzed ASX short interest report for the past week and highlight short interest changes in Ramelius Resources, Bluescope Steel, Boss Energy,...
Ke Yan, CFA, FRM
Follow
480 Views
Share
bullish
•
GQG Partners
•
31 Jul 2025 05:40
S&P/ASX Indices: Proposed Methodology Changes & The BIG September Rebalance
The market consultation ends in 2 weeks, and the conclusions should be announced soon after that. A lot of the stocks have moved significantly over...
Brian Freitas
Follow
1.6k Views
Share
bearish
•
Quantitative Analysis
•
24 Jul 2025 18:36
ASX Short Interest Weekly (Jul 18th): JB Hi-Fi, James Hardie Industries, Amcor, Iluka Resources
We analyzed ASX short interest report for the past week and highlight short interest changes in JB Hi-Fi, James Hardie Industries, Amcor, Iluka...
Ke Yan, CFA, FRM
Follow
532 Views
Share
bullish
•
REA Group Ltd
•
24 Jul 2025 16:24
Quiddity Leaderboard ASX Sep25: Exp ADDs Down Vs Exp DELs Since Methodology Change; Time to Reverse?
We believe the newly proposed methodology would be implemented during the September 2025 index review. The expected ADDs have been underperforming...
Janaghan Jeyakumar, CFA
Follow
659 Views
Share
First
Previous
1
2
3
4
5
6
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4
x